117 related articles for article (PubMed ID: 37863330)
1. USP10 promotes the progression of triple-negative breast cancer by enhancing the stability of TCF4 protein.
Yang JR; Lu YB; Su HX; Xiao Y; Pan Q; Su F; Zhang XB; Zhu KL; Guan QL; Ling XL
Biochem Pharmacol; 2023 Dec; 218():115864. PubMed ID: 37863330
[TBL] [Abstract][Full Text] [Related]
2. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer.
Ouyang SW; Liu TT; Liu XS; Zhu FX; Zhu FM; Liu XN; Peng ZH
FEBS Lett; 2019 Feb; 593(4):406-413. PubMed ID: 30604502
[TBL] [Abstract][Full Text] [Related]
3. USP10 Regulates ZEB1 Ubiquitination and Protein Stability to Inhibit ZEB1-Mediated Colorectal Cancer Metastasis.
Sun L; Yu J; Guinney J; Qin B; Sinicrope FA
Mol Cancer Res; 2023 Jun; 21(6):578-590. PubMed ID: 36940483
[TBL] [Abstract][Full Text] [Related]
4. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
5. USP10 inhibits lung cancer cell growth and invasion by upregulating PTEN.
Sun J; Li T; Zhao Y; Huang L; Sun H; Wu H; Jiang X
Mol Cell Biochem; 2018 Apr; 441(1-2):1-7. PubMed ID: 28852924
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability.
Yang Q; Yan D; Zou C; Xue Q; Lin S; Huang Q; Li X; Tang D; Chen X; Liu J
Exp Mol Med; 2022 Nov; 54(11):2047-2059. PubMed ID: 36434041
[TBL] [Abstract][Full Text] [Related]
7. TRIM65 Promotes Malignant Cell Behaviors in Triple-Negative Breast Cancer by Impairing the Stability of LATS1 Protein.
Lu Y; Xiao Y; Yang J; Su H; Zhang X; Su F; Tian B; Zhao D; Ling X; Zhang T
Oxid Med Cell Longev; 2022; 2022():4374978. PubMed ID: 36035221
[TBL] [Abstract][Full Text] [Related]
8. USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.
Li J; Gao R; Zhang J
Clin Breast Cancer; 2023 Feb; 23(2):162-175. PubMed ID: 36528490
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme USP10 promotes osteosarcoma metastasis and epithelial-mesenchymal transition by stabilizing YAP1.
Deng J; Yi X; Feng Z; Peng J; Li D; Li C; Deng B; Liu S; Sahu S; Hao L
Cancer Med; 2023 Jul; 12(13):14452-14467. PubMed ID: 37184153
[TBL] [Abstract][Full Text] [Related]
10. YY1-regulated LINC00152 promotes triple negative breast cancer progression by affecting on stability of PTEN protein.
Shen X; Zhong J; Yu P; Zhao Q; Huang T
Biochem Biophys Res Commun; 2019 Feb; 509(2):448-454. PubMed ID: 30594392
[TBL] [Abstract][Full Text] [Related]
11. UCHL1 contributes to insensitivity to endocrine therapy in triple-negative breast cancer by deubiquitinating and stabilizing KLF5.
Li J; Liang Y; Zhou S; Chen J; Wu C
Breast Cancer Res; 2024 Mar; 26(1):44. PubMed ID: 38468288
[TBL] [Abstract][Full Text] [Related]
12. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
[TBL] [Abstract][Full Text] [Related]
13. The deubiquitinating enzyme USP10 regulates the endocytic recycling of CFTR in airway epithelial cells.
Bomberger JM; Barnaby RL; Stanton BA
Channels (Austin); 2010; 4(3):150-4. PubMed ID: 20215869
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
Han Y; Yun CC
FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation.
He Y; Jiang S; Mao C; Zheng H; Cao B; Zhang Z; Zhao J; Zeng Y; Mao X
J Biol Chem; 2021 Sep; 297(3):101088. PubMed ID: 34416231
[TBL] [Abstract][Full Text] [Related]
16. USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2.
Ouchida AT; Kacal M; Zheng A; Ambroise G; Zhang B; Norberg E; Vakifahmetoglu-Norberg H
Biochem Biophys Res Commun; 2018 Aug; 502(4):429-434. PubMed ID: 29803676
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin specific protease 46 potentiates triple negative breast cancer development by stabilizing PGAM1-mediated glycolysis.
Ke L; Jia Z; Gao W; Luo L
Cell Biol Int; 2023 Jan; 47(1):41-51. PubMed ID: 36335636
[TBL] [Abstract][Full Text] [Related]
19. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
Wu D; Jia H; Zhang Z; Li S
Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
[TBL] [Abstract][Full Text] [Related]
20. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
Luo N; Zhang K; Li X; Hu Y
J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
